Inhibrx Biosciences, Inc. INBX Business Segments — Other segment expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The official record: Inhibrx Biosciences, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s business segments — other segment expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s business segments — other segment expenses?
- Inhibrx Biosciences, Inc. (INBX) reported business segments — other segment expenses of $500 in Q4 2025.
- How has Inhibrx Biosciences, Inc.'s business segments — other segment expenses changed year-over-year?
- Inhibrx Biosciences, Inc.'s business segments — other segment expenses decreased by 0.0% year-over-year, from $500 to $500.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s business segments — other segment expenses?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s business segments — other segment expenses has grown at a -96.5% compound annual growth rate (CAGR), from $1.64M to $2K.
- What does business segments — other segment expenses mean?
- Includes residual operating expenses that do not fall into the primary cost categories of the reportable segment. Tracking this helps ensure comprehensive coverage of all costs incurred to support the segment's business activities.